Open AccessEpoetin Alfa Study Amended to Include Survival as Additional Endpoint
Author(s) -
Gretchen Henkel
Publication year - 2001
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000313801.47479.b3
Subject(s) - epoetin alfa , medicine , clinical trial , clinical endpoint , erythropoietin , protocol (science) , placebo , randomized controlled trial , quality of life (healthcare) , family medicine , alternative medicine , nursing , pathology